PTJ
VIVS

Paul Tudor Jones’s VivoSim Labs VIVS Stock Holding History

Paul Tudor Jones’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-313
Closed -$238K – 1427
2017
Q1 		$238K Buy
313
+184
+143% +$146K 0.01% 1139
2016
Q4 		$105K Buy
129
+39
+43% +$31K ﹤0.01% 1302
2016
Q3 		$82K Sell
90
-84
-48% -$82.2K ﹤0.01% 1351
2016
Q2 		$155K Buy
174
+50
+40% +$33.5K ﹤0.01% 1462
2016
Q1 		$65K Hold
124
– – ﹤0.01% 1641
2015
Q4 		$74K Buy
124
+53
+75% +$38.4K ﹤0.01% 1556
2015
Q3 		$45K Sell
71
-496
-87% -$377K ﹤0.01% 1480
2015
Q2 		$513K Buy
+567
New +$634K 0.02% 760
2015
Q1 		– Sell
-50
Closed -$87K – 1648
2014
Q4 		$87K Sell
50
-77
-61% -$118K ﹤0.01% 1375
2014
Q3 		$194K Buy
+127
New +$230K 0.01% 1207
2014
Q2 		– Sell
-74
Closed -$136K – 1356
2014
Q1 		$136K Buy
+74
New +$172K 0.01% 1096

Other funds holding VIVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Paul Tudor Jones's VIVS Position: Q2 2017 in Review

Paul Tudor Jones sold out of VivoSim Labs (VIVS) in Q2 2017, closing a stake of 313 shares — an estimated $238K sold.

Paul Tudor Jones first reported a position in VIVS in Q1 2014 and held it in 11 quarters. The position peaked at $513K in Q2 2015. 117 funds tracked by Wall St. Rank hold VIVS as of Q2 2017.

  • Paul Tudor Jones reported no remaining VivoSim Labs position as of Q2 2017 after selling out during the quarter.
  • Paul Tudor Jones sold 313 VivoSim Labs shares in Q2 2017, an estimated $238K.
  • Paul Tudor Jones first reported a position in VivoSim Labs in Q1 2014 and held it in 11 quarters.
  • Paul Tudor Jones's VivoSim Labs position peaked at $513K in Q2 2015.
  • 117 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2017.

Based on Tudor Investment Corp's 13F filing for Q2 2017, filed 14 Aug 2017.